Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Eastham
    Eastham
  5. Jarnagin
    Jarnagin
  6. Reuter
    Reuter
  7. D'Angelica
    D'Angelica
  8. Kingham
    Kingham
  9. Ladanyi
    Ladanyi
  10. Scher
    Scher

Groups

  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)
  7. Epidemiology and Biostatistics (685)
  8. Sloan Kettering Institute Faculty (612)
  9. Department of Pathology and Laboratory Medicine (586)
  10. GSK Faculty (582)
Search Within
Formats
  1. Journal Article (3901)
  2. Meeting Abstract (1049)
  3. Editorial (165)
  4. Review (132)
  5. Correspondence (113)
  6. Guidelines (79)
  7. Research Letter (29)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)

More Groups

People
  1. Harry Herr (270)
  2. Andrew Vickers (223)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (161)
  6. William Jarnagin (157)

More People

Years
  1. 2025 (96)
  2. 2024 (256)
  3. 2023 (234)
  4. 2022 (264)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (762)
  2. European Urology (570)
  3. Lancet Oncology (394)
  4. Urology (388)
  5. Journal of the American College of Surgeons (346)
  6. Journal of Molecular Diagnostics (272)

More Publications

Results (5503)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): A randomised, placebo-controlled, double-blind, multinational, phase 3 study
    Journal Article

    Saad, F.; Efstathiou, E.; Attard, G.; Flaig, T. W.; Franke, F.; Goodman, O. B. Jr; Oudard, S.; Steuber, T.; Suzuki, H.; Wu, D.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Global guideline for the diagnosis and management of the endemic mycoses: An initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology
    Review

    Thompson, G. R. 3rd; Le, T.; Chindamporn, A.; Kauffman, C. A.; Alastruey-Izquierdo, A.; Ampel, N. M.; Andes, D. R.; Armstrong-James, D.; Ayanlowo, O.; Baddley, J. W.; more...
    Lancet Infectious Diseases (2021)

    Fulltext@MSK | Save
  • Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement
    Guidelines

    King, M. T.; Keyes, M.; Frank, S. J.; Crook, J. M.; Butler, W. M.; Rossi, P. J.; Cox, B. W.; Showalter, T. N.; Mourtada, F.; Potters, L.; more...
    Brachytherapy (2021)

    Fulltext@MSK | Save
  • Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer
    Journal Article

    Gorovets, D.; Hopkins, M.; Kollmeier, M.; Moore, A.; Goel, A.; Shasha, D.; Brennan, V.; McBride, S.; Cohen, G.; Damato, A. L.; more...
    Brachytherapy (2021)

    Fulltext@MSK | Save
  • Outcomes of ureteroneocystostomy in patients with cancer
    Journal Article

    Stearns, G. L.; Tin, A. L.; Benfante, N. E.; Sjoberg, D. D.; Sandhu, J. S.
    Urology (2021)

    Fulltext@MSK | Save
  • Individual patient data meta-analysis of discrimination of the four kallikrein panel associated with the inclusion of prostate volume
    Journal Article

    Vertosick, E. A.; Zappala, S.; Punnen, S.; Hugosson, J.; Boorjian, S. A.; Haese, A.; Carroll, P.; Cooperberg, M.; Bjartell, A.; Lilja, H.; more...
    Urology (2021)

    Fulltext@MSK | Save
  • When is a seminoma not a seminoma? The incidence, risk factors and management of patients with testicular seminoma with discordant elevated serum alpha-fetoprotein
    Journal Article

    Fero, K. E.; Lec, P. M.; Sharma, V.; Lenis, A. T.; Low, J.; Litwin, M. S.; Leapman, M. S.; Chamie, K.
    Urology (2021)

    Fulltext@MSK | Save
  • Functional and oncological outcomes of renal surgery for hilar tumors: Informing the decisions in risk-adapted management
    Journal Article

    Alvim, R. G.; Tin, A. L.; Nogueira, L.; Wong, N. C.; Fonseca, R. C.; Sjoberg, D. D.; Hakimi, A. A.; Touijer, K. A.; Russo, P.; Coleman, J. A.
    Urology (2021)

    Fulltext@MSK | Save
  • Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial
    Journal Article

    Banerjee, S.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Comments on the Letter: “Role of religious and spiritual aid in quarantine hospitalization due to SARS-COV-2” — What about existential needs of those who are without a religion?
    Correspondence

    Da Ponte, G.; Ouakinin, S.; Breitbart, W.
    Journal of the Academy of Consultation-Liaison Psychiatry (2021)

    Fulltext@MSK | Save